Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis

BACKGROUND: About 1.3 million pregnant women lived with HIV and were eligible to receive antiretroviral therapy (ART) worldwide in 2021. The World Health Organization recommends protease inhibitors (PI)-based regimen as second or third-line during pregnancy. With remaining pregnant women exposed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Saint-Lary, Laura, Benevent, Justine, Damase-Michel, Christine, Vayssière, Christophe, Leroy, Valériane, Sommet, Agnès
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885641/
https://www.ncbi.nlm.nih.gov/pubmed/36717801
http://dx.doi.org/10.1186/s12884-023-05347-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885641/
https://www.ncbi.nlm.nih.gov/pubmed/36717801
http://dx.doi.org/10.1186/s12884-023-05347-5

Ejemplares similares